[Advances in research on metabolic associated fatty liver disease in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiRao HY, Zhao JM, Yu CH, Mi YQ, Wei L.
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1999 目的:探讨慢性乙型肝炎血清透明质酸(HA)和抗-HBe 与肝组织病理改变的关系。方法: 对 170 例慢性乙型肝 炎患者进行肝活检,观察肝组织病理分级( G)和分期( S)情况, 同时检测 HA 及肝炎病毒标志物。 结果:①血清 HA 与肝组织病 理分级和分期关系密切,随着病理分级和分期的升高,HA 也逐渐升高,G4、S4 的血清 HA 分别比 G1、S1 显著升高(P
doaj
[Advances in basic and experimental diagnostic research on liver diseases in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiChen DB, Yang RF, Chen HS.
europepmc +1 more source
定量 PCR 分析 HBsAg 阳性肝癌患者 手术前后血清 HBV DNA 变化
Zhongshan Daxue xuebao. Yixue kexue ban, 1998 目的: 明确外科手术对 HBsAg 阳性肝癌患者乙型肝炎病毒(HBV)复制的影响。 方法: 以常规聚合酶链反应 ( PCR)方法检测了 20 例 HBV 血清学标志阳性肝癌患者血清中的 HBV DNA ; 应用荧光能量转移定量聚合酶链反应(QPCR) 测定肝癌手术切除前后病人血清中 HBV DNA 量的变化情况。结果: 在部分肝癌病人( 40%)血清中可以检测到 HBV DNA ; 外科手术后较手术前病人血清 HBV DNA 拷贝数增高(P
doaj
[A review of research progress in integrated traditional Chinese and Western Medicine for liver diseases]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhang Q +6 more
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1995 对１２８例有病理诊断依据的肝细胞场（ＨＣＣ）、４７例慢迁肝（ＣＰＨ）、１０５例慢活肝（ＣＡＨ）、４６例肝硬化（ＬＣ）．采用嵌套式ＰＣＲ技术检测其血标本中的丙型肝炎病毒（ＨＣｖ）ＲＮＡ和乙型肝炎病毒（ＨＢＶ）ＤＩＩＡ，对这两种病毒的血清学标志也进行了研究。结果：在ＨＣＣ组。ＨＣＶＲＮＡ１４．１％阳性，ＨＢＶＤＮＡ７ｉ．３％阳性。ＣＰＨ，ＣＡＨ，ＬＣ和ＨＣＣ的ＨＢＶ感染率均在９０％左右，而ＨＣＶ感染率则分别为８．５％、９．５％、１７．４％和１９．５％，显示ＨＣＶ感染率随肝病严重程度的增加而有增加的趋势 ...
doaj
[Periodontitis and Metabolic Dysfunction-Associated Fatty Liver Disease: From Oral Dysbiosis to Hepatic Metabolic Dysregulation]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanWang M +5 more
europepmc +1 more source
[Introduction to the recommendations of the EASL clinical practice guidelines for genetic cholestatic liver diseases]. [PDF]
Zhonghua Gan Zang Bing Za ZhiHou W, Zheng SJ.
europepmc +1 more source
[Recommendations from the European Association for the Study of the Liver and the European Reference Network for Rare Liver Diseases Clinical Practice Guidelines for hepatolenticular degeneration]. [PDF]
Zhonghua Gan Zang Bing Za ZhiTang S, Hou W, Zheng SJ.
europepmc +1 more source